Mantra Bio
Biotechnology, Life Science
Founded in 1/1/16
San Francisco, California, United States
For Profit
About Mantra Bio
Mantra Bio develops a novel next-generation, targeted therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). The Company's REVEAL platform, which integrates computational and wet biology, and automation, leverages the diversity of exosomes to enable the rational design of therapeutics directed at a wide range of tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process and related technologies to ensure this new class of therapeutics is reproducibly made at high purity.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 14 active products
Financial Information
- Estimated Revenue:
- Total Funding: 34000000 USD
- Last Funding: 9000000 USD (Series A)
- Funding Status: Early Stage Venture
Technology Stack
Mantra Bio actively uses 14 products in their tech stack.
Market Presence
Industries: Biotechnology, Life Science
Headquarters: San Francisco, California, United States
Employees
- Alex Mok - Co-Founder & Chief Executive Officer (LinkedIn)
- Maria Fuentes - Chief Scientific Officer (LinkedIn)